<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - CYTX</title>
<description>International Business News - CYTX</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Cytori Therapeutics shares fall on wider 2Q loss</title>
  <description>Shares of Cytori Therapeutics Inc., which develops technology to preserve and develop stem cells, plunged Friday after the company reported a wider-than-expected second-quarter loss and said it would raise money with a stock sale.</description>
    <link>http://www.ibtimes.com/articles/20080808/cytori-therapeutics-shares-fall-on-wider-2q-loss.htm</link> 
  <pubDate>Fri, 08 Aug 2008 11:27:48 EDT</pubDate>
  </item>


  <item>
  <title>Cytori selling stem-cell system in Singapore</title>
  <description>Cytori Therapeutics Inc., which develops technology to preserve and develop stem cells, said Monday it will sell one of its stem-cell systems to Astrea International for an undisclosed amount.</description>
    <link>http://www.ibtimes.com/articles/20080804/cytori-selling-stem-cell-system-in-singapore.htm</link> 
  <pubDate>Mon, 04 Aug 2008 13:56:05 EDT</pubDate>
  </item>


  <item>
  <title>Russell 2000 adds 53 health care companies</title>
  <description>More than 50 companies in the health care sector were added to the Russell 2000 in this year&amp;#39;s reconstitution of the small stock index, while 30 companies in the sector were removed from the index.</description>
    <link>http://www.ibtimes.com/articles/20080630/russell-2000-adds-53-health-care-companies.htm</link> 
  <pubDate>Mon, 30 Jun 2008 14:16:09 EDT</pubDate>
  </item>


  <item>
  <title>Geron shares recover after drop on study delay</title>
  <description>Shares of biotechnology company Geron Corp. regained some ground Thursday, following a prior-day plunge on the Food and Drug Administration&amp;#39;s decision to place a clinical hold on a planned stem-cell study.</description>
    <link>http://www.ibtimes.com/articles/20080515/geron-shares-recover-after-drop-on-study-delay.htm</link> 
  <pubDate>Thu, 15 May 2008 17:55:45 EDT</pubDate>
  </item>


</channel>
</rss>